Renaissance Technologies’s Akari Therapeutics AKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4K Sell
17,415
-969
-5% -$1.13K ﹤0.01% 3469
2025
Q1
$22.8K Sell
18,384
-5,081
-22% -$6.3K ﹤0.01% 3352
2024
Q4
$28.6K Buy
23,465
+5,396
+30% +$6.58K ﹤0.01% 3457
2024
Q3
$53.3K Buy
18,069
+1,000
+6% +$2.95K ﹤0.01% 3336
2024
Q2
$46.1K Buy
17,069
+2,300
+16% +$6.21K ﹤0.01% 3303
2024
Q1
$28K Buy
14,769
+4,500
+44% +$8.53K ﹤0.01% 3563
2023
Q4
$32K Sell
10,269
-7,200
-41% -$22.4K ﹤0.01% 3517
2023
Q3
$69K Buy
17,469
+1,556
+10% +$6.15K ﹤0.01% 3327
2023
Q2
$54K Buy
15,913
+1,735
+12% +$5.89K ﹤0.01% 3600
2023
Q1
$52K Buy
14,178
+11,405
+411% +$41.8K ﹤0.01% 3654
2022
Q4
$26K Buy
2,773
+770
+38% +$7.22K ﹤0.01% 3912
2022
Q3
$25K Sell
2,003
-295
-13% -$3.68K ﹤0.01% 3868
2022
Q2
$46K Sell
2,298
-15
-0.6% -$300 ﹤0.01% 4007
2022
Q1
$56K Sell
2,313
-701
-23% -$17K ﹤0.01% 3891
2021
Q4
$90K Sell
3,014
-254
-8% -$7.59K ﹤0.01% 3699
2021
Q3
$107K Sell
3,268
-4,302
-57% -$141K ﹤0.01% 3310
2021
Q2
$262K Buy
7,570
+932
+14% +$32.3K ﹤0.01% 3183
2021
Q1
$350K Buy
6,638
+1,255
+23% +$66.2K ﹤0.01% 3016
2020
Q4
$199K Sell
5,383
-49
-0.9% -$1.81K ﹤0.01% 3141
2020
Q3
$189K Sell
5,432
-1,250
-19% -$43.5K ﹤0.01% 3123
2020
Q2
$291K Buy
6,682
+210
+3% +$9.15K ﹤0.01% 3052
2020
Q1
$188K Sell
6,472
-2,125
-25% -$61.7K ﹤0.01% 3115
2019
Q4
$301K Buy
8,597
+1,815
+27% +$63.5K ﹤0.01% 3069
2019
Q3
$232K Buy
6,782
+32
+0.5% +$1.1K ﹤0.01% 3102
2019
Q2
$273K Buy
6,750
+5,800
+611% +$235K ﹤0.01% 3206
2019
Q1
$68K Buy
+950
New +$68K ﹤0.01% 3341